Asterand UK Limited
10Patents
6Active
10Granted
39Portfolio score
Filing activity: Feb 12, 2003 → Jan 28, 2009 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7803841B2 | EP2 receptor agonists | Chemistry; Metallurgy | 6 | Active |
| US7196089B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 5 | Expired |
| US7417068B2 | EP4 receptor antagonists | Human Necessities | 5 | Expired |
| US7569602B2 | Furan derivatives as EP4 receptor antagonists | Human Necessities | 4 | Expired |
| US8080567B2 | EP2 receptor agonists | Chemistry; Metallurgy | 2 | Active |
| US7662839B2 | EP2 receptor agonists | Chemistry; Metallurgy | 2 | Active |
| US7528157B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US7507754B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US7858644B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US7429607B2 | 5-HT2B receptor antagonists | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.